Key facts
- Bonumose’s last known valuation is $97.0M (Oct 2024).
- It has raised $59.6M across 3 recorded rounds; the latest was Early Stage VC ($41.0M) in Sep 2023.
- Notable investors include Plug and Play Tech Center, Virginia Innovation Partnership Corporation, Argonautic Ventures, iSelect Fund, ASR Group — 16 tracked in total.
- Bonumose has filed 5 Form Ds with the SEC since 2021, most recently Oct 2025 ($165K sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Bonumose
Funding rounds
3 roundsAbout Bonumose
Producer of raw food ingredients intended to offer a healthy alternative to sugar-infused products. The company specializes in the production of rare and natural sugar to facilitate glycemic control and improved gut health, as it is low-glycemic and non-cariogenic, enabling client companies to use sugar that is affordable and healthy in their processes.
- Sector
- Business Products and Services (B2B)
- HQ
- Charlottesville, VA, United States
- Founded
- 2016
- Employees
- 23
- Website
- bonumose.com/
- Ownership
- Privately Held (backing)
Bonumose doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bonumose shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bonumose in its N-PORT filings yet. We sweep new filings monthly.